Skip to main content
. 2022 Mar 31;19(1):224–235. doi: 10.14245/ns.2143084.542

Table 3.

Comparison of clinical outcomes between satisfied and dissatisfied subgroups at midterm follow-up by univariate analysis

Variable All patients (n=222) Functional improvement
Relief of back pain
Satisfied (n=206) Dissatisfied (n=16) p-value Satisfied (n = 213) Dissatisfied (n = 9) p-value
ODI score
Baseline 44.8 ± 19.9 45.6 ± 19.8 34.4 ± 18.8 0.030** 45.1 ± 19.8 34.4 ± 22.5 0.329
At 2 years 3.2 ± 7.4 1.5 ± 3.2 24.8 ± 11.5 < 0.001** 2.2 ± 5.0 26.4 ± 14.5 0.005**
SF-36 PF score
Baseline 52.1 ± 23.5 51.2 ± 23.1 64.7 ± 25.1 0.026** 51.7 ± 23.4 62.2 ± 24.5 0.189
At 2 years 97.5 ± 5.1 98.5 ± 2.7 84.4 ± 9.6 < 0.001** 98.1 ± 3.7 82.8 ± 10.9 0.003**
SF-36 BP score
Baseline 46.5 ± 19.0 45.7 ± 19.1 57.4 ± 14.7 0.017** 46.0 ± 19.1 59.6 ± 13.1 0.035**
At 2 years 96.0 ± 9.3 98.0 ± 5.0 70.1 ± 12.7 < 0.001** 97.2 ± 7.1 68.0 ± 11.8 < 0.001**
EQ-5D score
Baseline 0.53 ± 0.22 0.52 ± 0.23 0.63 ± 0.15 0.063* 0.52 ± 0.22 0.66 ± 0.13 0.070*
At 2 years 0.97 ± 0.07 0.99 ± 0.04 0.80 ± 0.12 < 0.001** 0.98 ± 0.05 0.77 ± 0.12 < 0.001**
VAS-back score
Baseline 3.94 ± 2.42 3.96 ± 2.42 3.69 ± 2.50 0.668 3.94 ± 2.42 3.89 ± 2.47 0.950
At 2 years 0.37 ± 0.86 0.20 ± 0.50 2.56 ± 1.41 < 0.001** 0.23 ± 0.51 3.67 ± 0.87 < 0.001**
VAS-leg score
Baseline 5.40 ± 1.92 5.40 ± 1.96 5.38 ± 1.41 0.963 5.42 ± 1.92 4.78 ± 2.12 0.326
At 2 years 0.19 ± 0.56 0.09 ± 0.31 1.44 ± 1.21 < 0.001** 0.15 ± 0.49 1.11 ± 1.17 0.038**

Values are presented as mean±standard deviation.

ODI, Oswestry Disability Index; SF-36 PF; 36-item Short Form Health Survey physical function; SF-36 BP, 36-item Short Form Health Survey bodily pain; EQ-5D, European quality of life-5 dimensions; VAS, visual analogue scale.

*

p<0.1.

**

p<0.05.